These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4793883)

  • 1. In vitro effect of virazole against influenza viruses.
    Togo Y
    Antimicrob Agents Chemother; 1973 Dec; 4(6):641-2. PubMed ID: 4793883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation of a new antiviral agent "virazole" against influenza virus infections.
    Suganuma T; Ishida N
    Tohoku J Exp Med; 1973 Aug; 110(4):405-6. PubMed ID: 4764146
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro effect of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) on deoxyribonucleic acid and ribonucleic acid viruses.
    Huffman JH; Sidwell RW; Khare GP; Witkowski JT; Allen LB; Robins RK
    Antimicrob Agents Chemother; 1973 Feb; 3(2):235-41. PubMed ID: 4208281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide.
    Sidwell RW; Huffman JH; Khare GP; Allen LB; Witkowski JT; Robins RK
    Science; 1972 Aug; 177(4050):705-6. PubMed ID: 4340949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of action of 1- -D-ribofuranosyl-1,2,4-triazole-3-carboxamide (Virazole), a new broad-spectrum antiviral agent.
    Streeter DG; Witkowski JT; Khare GP; Sidwell RW; Bauer RJ; Robins RK; Simon LN
    Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1174-8. PubMed ID: 4197928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiinfluenza virus activity of virazole by means of quantitative hemadsorption technique (author's transl)].
    Shinkai K; Nishimura T
    Uirusu; 1974 Aug; 24(2):175-80. PubMed ID: 4478988
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro and in vivo activities of anti-influenza virus compound T-705.
    Furuta Y; Takahashi K; Fukuda Y; Kuno M; Kamiyama T; Kozaki K; Nomura N; Egawa H; Minami S; Watanabe Y; Narita H; Shiraki K
    Antimicrob Agents Chemother; 2002 Apr; 46(4):977-81. PubMed ID: 11897578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ribavirin triphosphate on primer generation and elongation during influenza virus transcription in vitro.
    Wray SK; Gilbert BE; Knight V
    Antiviral Res; 1985 Feb; 5(1):39-48. PubMed ID: 3985607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of virazole on the antiviral activity of poly(G) X poly(C) and other polyribonucleotide interferonogens].
    Vil'ner LM; Lashkevich VA
    Antibiotiki; 1984 Jun; 29(6):450-3. PubMed ID: 6089650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plaque inhibition assay for drug susceptibility testing of influenza viruses.
    Hayden FG; Cote KM; Douglas RG
    Antimicrob Agents Chemother; 1980 May; 17(5):865-70. PubMed ID: 7396473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir.
    Takashita E; Ejima M; Ogawa R; Fujisaki S; Neumann G; Furuta Y; Kawaoka Y; Tashiro M; Odagiri T
    Antiviral Res; 2016 Aug; 132():170-7. PubMed ID: 27321665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression by 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (virazole, ICN 1229) of influenza virus-induced infections in mice.
    Khare GP; Sidwell RW; Witkowski JT; Simon LN; Robins RK
    Antimicrob Agents Chemother; 1973 Apr; 3(4):517-22. PubMed ID: 4790606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Favipiravir, a new concept of antiviral drug against influenza viruses].
    Reina J; Reina N
    Rev Esp Quimioter; 2017 Apr; 30(2):79-83. PubMed ID: 28176519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the inhibiting action of virazole on the reproduction of the vaccinia virus in tissue culture].
    Chizhov NP
    Vopr Virusol; 1979; (3):259-62. PubMed ID: 380162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiviral activities of ribavirin, 5-ethynyl-1-beta-D-ribofuranosylimidazole-4-carboxamide, and 6'-(R)-6'-C-methylneplanocin A against several ortho- and paramyxoviruses.
    Shigeta S; Mori S; Baba M; Ito M; Honzumi K; Nakamura K; Oshitani H; Numazaki Y; Matsuda A; Obara T
    Antimicrob Agents Chemother; 1992 Feb; 36(2):435-9. PubMed ID: 1605607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative activity of amantadine and ribavirin against influenza virus in vitro: possible clinical relevance.
    Browne MJ; Moss MY; Boyd MR
    Antimicrob Agents Chemother; 1983 Mar; 23(3):503-5. PubMed ID: 6847176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of influenza RNA synthesis by virazole (ribavirin).
    Scholtissek C
    Arch Virol; 1976; 50(4):349-52. PubMed ID: 1275709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double-blind clinical assessment of ribavirin (virazole) in the prevention of induced infection with type B influenza virus.
    Togo Y; McCracken EA
    J Infect Dis; 1976 Jun; 133 Suppl():A109-13. PubMed ID: 778306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe.
    Pozo F; Lina B; Andrade HR; Enouf V; Kossyvakis A; Broberg E; Daniels R; Lackenby A; Meijer A;
    J Clin Virol; 2013 May; 57(1):5-12. PubMed ID: 23375738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MTT colorimetric assay system for the screening of anti-orthomyxo- and anti-paramyxoviral agents.
    Watanabe W; Konno K; Ijichi K; Inoue H; Yokota T; Shigeta S
    J Virol Methods; 1994 Jul; 48(2-3):257-65. PubMed ID: 7989442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.